Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 42Gastrointestinal 40Head & Neck 11Thoracic 10Gynecologic 9Other hematologic neoplasm 8Tumor-Agnostic 7Genitourinary 6Lymphoid 4Endocrine 3Sarcoma 2CNS 2Plasma cell 1Other solid neoplasm 1Other neoplasm 1Other 1NET 1Dermatologic 1Classical hematology 1

Conditions

Sarcoma 1Gastrointestinal Stromal Tumors 1

Interventions

Radiotherapy 215Cyclophosphamide 210Doxorubicin 207Temozolomide 181Ifosfamide 121Filgrastim 111Etoposide 101Imatinib Mesylate 99Vincristine 92Gemcitabine 89Bevacizumab 83Irinotecan 79Magnetic Resonance Spectroscopy 78pembrolizumab 75Radiation 66Carboplatin 65pazopanib 60Methotrexate 60Nivolumab 58Cisplatin 58fludarabine phosphate 56Peripheral Blood Stem Cell Transplantation 56Specimen Handling 53Docetaxel 50Busulfan 48Trabectedin 47Biopsy 47Melphalan 46Surgical Procedures, Operative 44Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Control Groups × Sarcoma × Clear all
NCT06772233 2025-07-31

A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment

Peking University

Phase 2 Not yet recruiting
100 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT04518488 2020-09-21

Prehabilitation Soft-Tissue Sarcoma of Lower Limb

McGill University

Phase NA Unknown
30 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡